Rice Hall James & Associates LLC Acquires New Shares in Viemed Healthcare, Inc. $VMD

Rice Hall James & Associates LLC bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 209,066 shares of the company’s stock, valued at approximately $2,383,000.

Several other institutional investors have also recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new position in shares of Viemed Healthcare in the fourth quarter worth $25,000. Kemnay Advisory Services Inc. purchased a new position in shares of Viemed Healthcare in the fourth quarter valued at $46,000. Quarry LP bought a new stake in shares of Viemed Healthcare during the 3rd quarter valued at $48,000. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 1st quarter valued at $90,000. Finally, R Squared Ltd purchased a new stake in Viemed Healthcare during the 4th quarter worth about $102,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Insider Buying and Selling

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director directly owned 75,518 shares in the company, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William Frazier sold 10,000 shares of Viemed Healthcare stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This trade represents a 12.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 20.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Freedom Capital downgraded Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Wall Street Zen cut Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Weiss Ratings raised shares of Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Viemed Healthcare currently has an average rating of “Hold”.

Viemed Healthcare Stock Up 0.8%

VMD opened at $9.12 on Wednesday. The business’s fifty day simple moving average is $11.07 and its 200 day simple moving average is $9.85. Viemed Healthcare, Inc. has a 52 week low of $6.05 and a 52 week high of $12.61. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. The stock has a market cap of $347.38 million, a PE ratio of 25.33 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%.The firm had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. As a group, research analysts expect that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current fiscal year.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.